Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients

Scikit-learn: Machine Learning in Python

Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016 · see citing works

Global cancer statistics

Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,708 · see citing works

XGBoost: A Scalable Tree Boosting System

Chen, T., & Guestrin, C. (2016) · Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining · doi:10.1145/2939672.2939785 · Cited by 54,569 · see citing works

Tissue-based map of the human proteome

Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286 · see citing works

XGBoost: A Scalable Tree Boosting System

Chen, T., & Guestrin, C. (2016) · arXiv · doi:10.48550/arxiv.1603.02754 · Cited by 7,104 · see citing works

Global quantification of mammalian gene expression control

Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 2× · see citing works

Screening and Prostate-Cancer Mortality in a Randomized European Study

Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., KWIATKOWSKI, M. K., Lujan, M., Lilja, H. G., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,016 · see citing works

Integrative Genomic Profiling of Human Prostate Cancer

Taylor, B. S., Schultz, N. D., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E. G., Reva, B. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,653 · see citing works

The Molecular Taxonomy of Primary Prostate Cancer

Abeshouse, A. A., Ahn, J., Akbani, R., Ally, A., Amin, S. B., Andry, C., Annala, M., Aprikian, A. G., Armenia, J., Arora, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.025 · Cited by 3,082 · see citing works

Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate

Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., & Redwine, E. A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171501 · Cited by 2,448 · see citing works

Androgen Receptor in Prostate Cancer

Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780 · see citing works

Radical Prostatectomy versus Observation for Localized Prostate Cancer

Wilt, T. J., Brawer, M. K., Jones, K. M., Barry, M. J., Aronson, W. J., Fox, S., Gingrich, J. R., Wei, J. T., Gilhooly, P. E., Grob, B. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113162 · Cited by 1,767 · see citing works

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

Beltran, H., Prandi, D., Mosquera, J. M., Benelli, M., Puca, L., Cyrta, J., Marotz, C. A., Γιαννοπούλου, Ε., Chakravarthi, B. V. S. K., Varambally, S., et al. (2016) · Nature Medicine · doi:10.1038/nm.4045 · Cited by 1,669 · see citing works

Selected reaction monitoring for quantitative proteomics: a tutorial

Lange, V., Picotti, P., Domon, B., & Aebersold, R. H. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.61 · Cited by 1,396 · see citing works

20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer

Albertsen, P. C. (2005) · JAMA · doi:10.1001/jama.293.17.2095 · Cited by 1,186 · see citing works

Male Reproductive Function and Semen

Mann, T. R. R., & Lutwak‐Mann, C. (1981) · Springer eBooks · doi:10.1007/978-1-4471-1300-3 · Cited by 1,094 · see citing works

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Bussemakers, M. J. G., van Bokhoven, A., Verhaegh, G. W. C. T., Smit, F. P., Karthaus, H. F. M., Schalken, J. A., Debruyne, F. M. J., Ru, N., & Isaacs, W. B. (1999) · PubMed · Cited by 1,051 · see citing works

The long tail of oncogenic drivers in prostate cancer

PCF/SU2C International Prostate Cancer Dream Team, Armenia, J., Wankowicz, S. A. M., Liu, D., Gao, J., Kundra, R., Reznik, E., Chatila, W. K., Chakravarty, D., Han, G. C., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0078-z · Cited by 873 · see citing works

Purification of a Human Prostate Specific Antigen

Wang, M. C., Valenzuela, L., Murphy, G. P., & Chu, T. M. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.10.100 · Cited by 825 · see citing works

Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement

Lee, J. W., Devanarayan, V., Barrett, Y. C., WEINER, R. S., Allinson, J. L., Fountain, S. T., Keller, S., Weinryb, I., Green, M., Duan, L., et al. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9045-3 · Cited by 770 · see citing works

Genomic hallmarks of localized, non-indolent prostate cancer

Fraser, M. E., Sabelnykova, V. Y., Yamaguchi, T. N., Heisler, L. E., Livingstone, J. M., Huang, V., Shiah, Y.-J., Yousif, F., Lin, X., Masella, A. P., et al. (2017) · Nature · doi:10.1038/nature20788 · Cited by 589 · see citing works

Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach

Carr, S. A., Abbatiello, S. E., Ackermann, B. L., Borchers, C., Domon, B., Deutsch, E. W., Grant, R. P., Hoofnagle, A. N., Hüttenhain, R., Koomen, J. M., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036095 · Cited by 561 · see citing works

AN “ ACID ” PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND

Gutman, A. B., & GUTMAN, E. B. (1938) · Journal of Clinical Investigation · doi:10.1172/jci100974 · Cited by 555 · see citing works

PURIFICATION OF A HUMAN PROSTATE SPECIFIC ANTIGEN

Wang, M. C., Valenzuela, L., Murphy, G. P., & Chue, T. M. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65270-6 · Cited by 549 · see citing works

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

Grönberg, H., Adolfsson, J., Aly, M., Nordström, T., Wiklund, P. N., Brandberg, Y., Thompson, J., Wiklund, F. E., Lindberg, J., Clements, M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00361-7 · Cited by 410 · see citing works

Detection of TMPRSS2-ERG Fusion Transcripts and Prostate Cancer Antigen 3 in Urinary Sediments May Improve Diagnosis of Prostate Cancer

Hessels, D., Smit, F. P., Verhaegh, G. W. C. T., Witjes, J. A., Cornel, E. B., & Schalken, J. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0700 · Cited by 335 · see citing works

Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer

Goldkorn, A., Ely, B., Quinn, D. I., Tangen, C. M., Fink, L. M., Xu, T., Twardowski, P. W., Veldhuizen, P. J. V., Agarwal, N., Carducci, M. A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.7417 · Cited by 321 · see citing works

The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers

Tomlins, S. A., Rhodes, D. R., Yu, J., Varambally, S., Mehra, R., Perner, S., Demichelis, F., Helgeson, B. E., Laxman, B., Morris, D. S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.016 · Cited by 315 · see citing works

Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome

Kusebauch, U., Campbell, D. S., Deutsch, E. W., Chu, C. S., Spicer, D. A., Brusniak, M.-Y., Slagel, J., Sun, Z., Stevens, J., Grimes, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.041 · Cited by 310 · see citing works

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer

Nordström, T., Vickers, A. J., Assel, M. J., Lilja, H. G., Grönberg, H., & Eklund, M. (2014) · European Urology · doi:10.1016/j.eururo.2014.08.010 · Cited by 220 · see citing works

SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression

Gan, W., Dai, X., Lunardi, A., Li, Z., Inuzuka, H., Liu, P., Varmeh, S., Zhang, J., Liang Cheng, C., Sun, Y., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.026 · Cited by 214 · see citing works

Seminal plasma as a diagnostic fluid for male reproductive system disorders

Drabovich, A. P., Saraon, P., Jarvi, K. A., & Diamandis, E. P. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.74 · Cited by 211 · see citing works

The discovery of prostate‐specific antigen

Rao, A. R., Motiwala, H. G., & Karim, O. M. A. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07138.x · Cited by 206 · see citing works

Proteomic Analysis of Seminal Plasma from Normal Volunteers and Post-Vasectomy Patients Identifies over 2000 Proteins and Candidate Biomarkers of the Urogenital System

Batruch, I., Lecker, I., Kagedan, D. J., Smith, C. R., Mullen, B. M., Grober, E. D., Lo, K. C., Diamandis, E. P., & Jarvi, K. A. (2010) · Journal of Proteome Research · doi:10.1021/pr100745u · Cited by 174 · see citing works

Seminal biomarkers for the evaluation of male infertility

Bieniek, J. M., Drabovich, A. P., & Lo, K. C. (2016) · Asian Journal of Andrology · doi:10.4103/1008-682x.175781 · Cited by 170 · see citing works

Differential Diagnosis of Azoospermia with Proteomic Biomarkers ECM1 and TEX101 Quantified in Seminal Plasma

Drabovich, A. P., Dimitromanolakis, A., Saraon, P., Soosaipillai, A. R., Batruch, I., Mullen, B. M., Jarvi, K. A., & Diamandis, E. P. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006260 · Cited by 169 · see citing works

Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein

Robert, M., & Gagnon, C. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050346 · Cited by 167 · see citing works

[Some physico-chemical characteristics of " -seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII].

Hara, M., Koyanagi, Y., Inoue, T., & Fukuyama, T. (1971) · PubMed · Cited by 145 · see citing works

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer

Kim, Y., Jeon, J., Mejia, S., Yao, C. Q., Ignatchenko, V., Nyalwidhe, J. O., Gramolini, A. O., Lance, R. S., Troyer, D. A., Drake, R. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11906 · Cited by 125 · see citing works

Verification of Male Infertility Biomarkers in Seminal Plasma by Multiplex Selected Reaction Monitoring Assay

Drabovich, A. P., Jarvi, K. A., & Diamandis, E. P. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.004127 · Cited by 113 · see citing works

Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer

Sequeiros, T., Rigau, M., Chiva, C., Montes, M., Garcia-Grau, I., García, M., Díaz, S., Celma, A., Bijnsdorp, I. V., Campos, A. R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13634 · Cited by 113 · see citing works

The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential

Ström, P., Nordström, T., Aly, M., Egevad, L., Grönberg, H., & Eklund, M. (2018) · European Urology · doi:10.1016/j.eururo.2017.12.028 · Cited by 110 · see citing works

Risk score predicts high‐grade prostate cancer in DNA‐methylation positive, histopathologically negative biopsies

Neste, L. V., Partin, A. W., Stewart, G. D., Epstein, J. I., Harrison, D. J., & Criekinge, W. V. (2016) · The Prostate · doi:10.1002/pros.23191 · Cited by 99 · see citing works

Comparative Assessment of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG Gene Fusion with the Serum [−2]Proprostate-Specific Antigen–Based Prostate Health Index for Detection of Prostate Cancer

Stephan, C., Jung, K., Semjonow, A., Schulze‐Forster, K., Cammann, H., Hu, X., Meyer, H., Bögemann, M., Miller, K., & Friedersdorff, F. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.195560 · Cited by 93 · see citing works

Identification of Differentially Expressed Proteins in Direct Expressed Prostatic Secretions of Men with Organ-confined Versus Extracapsular Prostate Cancer

Kim, Y., Ignatchenko, V., Yao, C. Q., Kalatskaya, I., Nyalwidhe, J. O., Lance, R. S., Gramolini, A. O., Troyer, D. A., Stein, L. D., Boutros, P. C., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.017889 · Cited by 92 · see citing works

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer

Ahn, J., Berndt, S. I., Wacholder, S., Kraft, P., Kibel, A. S., Yeager, M., Albanes, D., Giovannucci, E. L., Stampfer, M. J., Virtamo, J. R. K., et al. (2008) · Nature Genetics · doi:10.1038/ng0908-1032 · Cited by 92 · see citing works

COMPARISON OF THE INCIDENCE OF LATENT PROSTATE CANCER DETECTED AT AUTOPSY BEFORE AND AFTER THE PROSTATE SPECIFIC ANTIGEN ERA

Konety, B. R., Bird, V. Y., Deorah, S., & Dahmoush, L. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000177470.84735.55 · Cited by 91 · see citing works

Multicenter European External Validation of a Prostate Health Index–based Nomogram for Predicting Prostate Cancer at Extended Biopsy

Giovanni Lughezzani, A., Lazzeri, M., Haese, A., McNicholas, T., TAILLE, A. D. L., Buffi, N. M., Fossati, N., Lista, G., Larcher, A., Abrate, A., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.12.005 · Cited by 89 · see citing works

Quantitative Analysis of Energy Metabolic Pathways in MCF-7 Breast Cancer Cells by Selected Reaction Monitoring Assay

Drabovich, A. P., Pavlou, M. P., Dimitromanolakis, A., & Diamandis, E. P. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015214 · Cited by 88 · see citing works

Toward an integrated pipeline for protein biomarker development

Drabovich, A. P., Martínez‐Morillo, E., & Diamandis, E. P. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.09.006 · Cited by 83 · see citing works

Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer

Saraon, P., Musrap, N., Cretu, D., Karagiannis, G. S., Batruch, I., Smith, C. R., Drabovich, A. P., Trudel, D., van der Kwast, T., Morrissey, C. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384438 · Cited by 81 · see citing works

Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility

Korbakis, D., Schiza, C., Brinc, D., Soosaipillai, A. R., Karakosta, T. D., Légaré, C., Sullivan, R., Mullen, B. M., Jarvi, K. A., Diamandis, E. P., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0817-5 · Cited by 78 · see citing works

Analysis of Seminal Plasma from Patients with Non-obstructive Azoospermia and Identification of Candidate Biomarkers of Male Infertility

Batruch, I., Smith, C. R., Mullen, B. M., Grober, E. D., Lo, K. C., Diamandis, E. P., & Jarvi, K. A. (2011) · Journal of Proteome Research · doi:10.1021/pr200812p · Cited by 78 · see citing works

Mechanisms of Androgen-Independent Prostate Cancer.

Saraon, P., Drabovich, A. P., Jarvi, K. A., & Diamandis, E. P. (2014) · PubMed Central · Cited by 74 · see citing works

Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery

Tănase, C., Codrici, E., Popescu, I. D., Mihai, S., Enciu, A., Necula, L. G., Preda, A., Ismail, G., & Albulescu, R. (2017) · Oncotarget · doi:10.18632/oncotarget.14501 · Cited by 73 · see citing works

One Man at a Time — Resolving the PSA Controversy

McNaughton‐Collins, M., & Barry, M. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1111894 · Cited by 73 · see citing works

Mutations and polymorphisms in thep53, p21 andp16 genes in oral carcinomas of Indian betel quid chewers

Heinzel, P. A., Balaram, P., & Bernard, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961115)68:4 · Cited by 70 · see citing works

Assessment of Peptide Chemical Modifications on the Development of an Accurate and Precise Multiplex Selected Reaction Monitoring Assay for Apolipoprotein E Isoforms

Martínez‐Morillo, E., Nielsen, H. M., Batruch, I., Drabovich, A. P., Begcevic, I., Lopez, M. F., Minthon, L., Bu, G., Mattsson, N., Portelius, E., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr401060x · Cited by 67 · see citing works

Combinatorial Peptide Libraries Facilitate Development of Multiple Reaction Monitoring Assays for Low-Abundance Proteins

Drabovich, A. P., & Diamandis, E. P. (2010) · Journal of Proteome Research · doi:10.1021/pr900729g · Cited by 60 · see citing works

FOXA1 mutations in hormone-dependent cancers

Robinson, J. L. L., Holmes, K. A., & Carroll, J. S. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00020 · Cited by 58 · see citing works

Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays

Karakosta, T. D., Soosaipillai, A. R., Diamandis, E. P., Batruch, I., & Drabovich, A. P. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.057695 · Cited by 55 · see citing works

Going to extremes: determinants of extraordinary response and survival in patients with cancer

Saner, F. A. M., Herschtal, A., Nelson, B. H., DeFazio, A., Goode, E. L., Ramus, S. J., Pandey, A., Beach, J. A., Fereday, S., Berchuck, A., et al. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0145-5 · Cited by 51 · see citing works

Seminal Plasma as a Source of Prostate Cancer Peptide Biomarker Candidates for Detection of Indolent and Advanced Disease

Neuhaus, J., Schiffer, E., von Wilcke, P., Bauer, H. W., Leung, H. Y., Siwy, J., Ulrici, W., Paasch, U., Horn, L., & Stolzenburg, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067514 · Cited by 48 · see citing works

Metabolomic Imaging for Human Prostate Cancer Detection

Wu, C., Jordan, K. W., Ratai, E., Sheng, J., Adkins, C. B., DeFeo, E. M., Jenkins, B. G., Ying, L. L., McDougal, W. S., & Cheng, L. L. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000513 · Cited by 47 · see citing works

Immunocapture-Selected Reaction Monitoring Screening Facilitates the Development of ELISA for the Measurement of Native TEX101 in Biological Fluids*

Korbakis, D., Brinc, D., Schiza, C., Soosaipillai, A. R., Jarvi, K. A., Drabovich, A. P., & Diamandis, E. P. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.047571 · Cited by 43 · see citing works

Identification of TEX101-associated Proteins Through Proteomic Measurement of Human Spermatozoa Homozygous for the Missense Variant rs35033974*

Schiza, C., Korbakis, D., Jarvi, K. A., Diamandis, E. P., & Drabovich, A. P. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001170 · Cited by 38 · see citing works

Mining Human Prostate Cancer Datasets: The “camcAPP” Shiny App

Dunning, M., Vowler, S. L., Lalonde, E., Ross‐Adams, H., Boutros, P. C., Mills, I. G., Lynch, A. G., & Lamb, A. D. G. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.02.022 · Cited by 38 · see citing works

Dynamics of Protein Expression Reveals Primary Targets and Secondary Messengers of Estrogen Receptor Alpha Signaling in MCF-7 Breast Cancer Cells

Drabovich, A. P., Pavlou, M. P., Schiza, C., & Diamandis, E. P. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.057257 · Cited by 36 · see citing works

The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway

Jiang, W. G., Ablin, R. J., Kynaston, H., & Mason, M. D. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.09.010 · Cited by 35 · see citing works

Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndrome

Cho, C.-K. J., Drabovich, A. P., Karagiannis, G. S., Martínez‐Morillo, E., Dason, S., Dimitromanolakis, A., & Diamandis, E. P. (2013) · Clinical Proteomics · doi:10.1186/1559-0275-10-2 · Cited by 30 · see citing works

Development of a Multiplex Selected Reaction Monitoring Assay for Quantification of Biochemical Markers of Down Syndrome in Amniotic Fluid Samples

Martínez‐Morillo, E., Cho, C.-K. J., Drabovich, A. P., Shaw, J. L. V., Soosaipillai, A. R., & Diamandis, E. P. (2012) · Journal of Proteome Research · doi:10.1021/pr300355a · Cited by 29 · see citing works

Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.

Davies, G., Ablin, R. J., Mason, M. D., & Jiang, W. G. (2007) · PubMed · Cited by 29 · see citing works

Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer

Cho, S., Choi, K., Jeon, J., Kim, C.-W., Shin, D., Lee, J. B., Lee, S. E., Kim, C., Park, J., Jeong, E. M., et al. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.4.031 · Cited by 28 · see citing works

Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer

Flores‐Morales, A., & Iglesias‐Gato, D. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00267 · Cited by 22 · see citing works

Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain

Jiang, W. G., Ye, L., Sanders, A. J., Ruge, F., Kynaston, H., Ablin, R. J., & Mason, M. D. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-269 · Cited by 19 · see citing works

Overexpression of transglutaminase 4 and prostate cancer progression: a potential predictor of less favourable outcomes

Cao, Z., Wang, Y., Liu, Z., Zhang, Z., Ren, S., Yu, Y., Qiao, M., Zhai, B., & Ying-hao, S. U. N. (2013) · Asian Journal of Andrology · doi:10.1038/aja.2013.79 · Cited by 19 · see citing works

Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression

Bhowal, A., Majumder, S., Ghosh, S., Basu, S., Sen, D., Roychowdhury, S., Sengupta, S., & Chatterji, U. (2017) · Scientific Reports · doi:10.1038/s41598-017-10068-9 · Cited by 16 · see citing works

Immunocytochemical localization of MG1 mucin in human bulbourethral glands

Piludu, M., Hand, A. R., Cossu, M., & Piras, M. (2008) · Journal of Anatomy · doi:10.1111/j.1469-7580.2008.01018.x · Cited by 13 · see citing works

Monoclonal Antibodies to Human Transglutaminase 4

Cho, S., Jeon, J., Kim, C.-W., Shin, D., Jang, G.-Y., Jeong, E. M., Lee, S. E., Song, K.-Y., & Kim, I. G. (2010) · Hybridoma · doi:10.1089/hyb.2009.0112 · Cited by 5 · see citing works

Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools

Nicora, G., Vitali, F., Dagliati, A., Geifman, N., & Bellazzi, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01030 · Cited by 284 · see citing works

Beyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics

Ferrara, F., Zoupanou, S., Primiceri, E., Ali, Z., & Chiriacò, M. S. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113698 · Cited by 46 · see citing works

Seminal Plasma Proteome as an Indicator of Sperm Dysfunction and Low Sperm Motility in Chickens

Li, Y., Sun, Y., Ni, A., Shi, L., Wang, P., Isa, A. M., Ge, P., Jiang, L., Fan, J., Ma, H., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002017 · Cited by 46 · see citing works

Plasma Metabolomics Reveals Metabolic Profiling For Diabetic Retinopathy and Disease Progression

Sun, Y., Zou, H., Li, X., Xu, S., & Liu, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.757088 · Cited by 45 · see citing works

Mapping Isoform Abundance and Interactome of the Endogenous TMPRSS2-ERG Fusion Protein by Orthogonal Immunoprecipitation–Mass Spectrometry Assays

Fu, Z., Rais, Y., Bismar, T. A., Hyndman, M. E., Le, X. C., & Drabovich, A. P. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100075 · Cited by 32 · see citing works

An overview of advances in multi-omics analysis in prostate cancer

Zhang, E., Zhang, M., Shi, C., Sun, L., Shan, L., Zhang, H., & Song, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118376 · Cited by 26 · see citing works

High Throughput LC-MS Platform for Large Scale Screening of Bioactive Polar Lipids in Human Plasma and Serum

Munjoma, N. C., Isaac, G., Muazzam, A., Cexus, O., Azhar, F., Pandha, H., Whetton, A. D., Townsend, P. A., Wilson, I. D., Gethings, L. A., et al. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00297 · Cited by 23 · see citing works

Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants

Rais, Y., Fu, Z., & Drabovich, A. P. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09325-x · Cited by 21 · see citing works

Redefining serological diagnostics with immunoaffinity proteomics

Walter, J., Eludin, Z., & Drabovich, A. P. (2023) · Clinical Proteomics · doi:10.1186/s12014-023-09431-y · Cited by 20 · see citing works

Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies

Bernardino, R. M. M., Leao, R. R. N., Henrique, R., Pinheiro, L. C., Kumar, P., Suravajhala, P., Beck, H. C., Carvalho, A. S., & Matthiesen, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413605 · Cited by 18 · see citing works

Germ Cell–Specific Proteins AKAP4 and ASPX Facilitate Identification of Rare Spermatozoa in Non-Obstructive Azoospermia

Zhang, J., Kanoatov, M., Jarvi, K. A., Gauthier-Fisher, A., Moskovtsev, S. I., Librach, C. L., & Drabovich, A. P. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100556 · Cited by 17 · see citing works

Dysregulation of Key Proteins Associated with Sperm Motility and Fertility Potential in Cancer Patients

Selvam, M. K. P., Finelli, R., Baskaran, S., & Agarwal, A. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186754 · Cited by 17 · see citing works

Rational Design and Development of SARS-CoV-2 Serological Diagnostics by Immunoprecipitation-Targeted Proteomics

Fu, Z., Rais, Y., Dara, D., Jackson, D., & Drabovich, A. P. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c01325 · Cited by 17 · see citing works

Advances in mass spectrometry for metabolomics: Strategies, challenges, and innovations in disease biomarker discovery

Titkare, N., Chaturvedi, S., Borah, S., & Sharma, N. (2024) · Biomedical Chromatography · doi:10.1002/bmc.6019 · Cited by 15 · see citing works

Prostate cancer in omics era

Gholami, N., Haghparast, A., Alipourfard, I., & Nazari, M. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02691-y · Cited by 16 · see citing works

Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables

Gabriele, C., Aracri, F., Prestagiacomo, L. E., Rota, M. A., Alba, S., Tradigo, G., Guzzi, P. H., Cuda, G., Damiano, R., Veltri, P., et al. (2023) · Clinical Proteomics · doi:10.1186/s12014-023-09439-4 · Cited by 13 · see citing works

Label-free peptide quantification coupled with in silico mapping of proteases for identification of potential serum biomarkers in gastric adenocarcinoma patients

de Oliveira, T. M., Lacerda, J. T., Leite, G. G. F., Dias, M., Mendes, M. A., Kassab, P., Silva, C. G. S. E., Juliano, M. A., & Forones, N. M. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.02.010 · Cited by 11 · see citing works

Cohort profile: the Alberta Prostate Cancer Research Initiative (APCaRI) Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, Canada

Vásquez, C., Kolinsky, M. P., Djebah, R., Uhlich, M., Donnelly, B. J., Fairey, A., Hyndman, E., Usmani, N., Wu, J. S.-Y., Venner, P. M., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037222 · Cited by 11 · see citing works

Identification and Quantification of Human Relaxin Proteins by Immunoaffinity-Mass Spectrometry

Rais, Y., & Drabovich, A. P. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00027 · Cited by 8 · see citing works

Opportunities and Challenges of Multiomics for Discovery and Monitoring of Human Pathogens

Turner, Z., & Drabovich, A. P. (2025) · Environment & Health · doi:10.1021/envhealth.5c00040 · Cited by 7 · see citing works

Biochemical Characterisation of Human Transglutaminase 4

Csobán-Szabó, Z., Bécsi, B., Alaoui, S. E., Fésüs, L., Korponay-Szabo, I. R., & Király, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212448 · Cited by 6 · see citing works

An overview of multiomics: a powerful tool applied in cancer molecular subtyping for cancer therapy

Zou, Y., Zhao, Z., & Song, Y. (2023) · Malignancy Spectrum · doi:10.1002/msp2.16 · Cited by 6 · see citing works

Transglutaminase-4 (Prostate Transglutaminase), a Potential Biological Factor and Clinical Indicator for the Diagnosis and Prognosis of Prostate Cancer

Ye, L., Sanders, A. J., & Jiang, W. G. (2022) · Anticancer Research · doi:10.21873/anticanres.16162 · Cited by 5 · see citing works

Noninvasive biomarkers to guide intervention: toward personalized patient management in prostate cancer

Frantzi, M., Gómez‐Gómez, E., & Mischak, H. (2020) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2020.1804866 · Cited by 5 · see citing works

Human Transglutaminases: Updated Insights into Activation Mechanisms, Allosteric Regulation and Disease

Moya-Garrido, P., Cano-Gómez, L. P., Ibarra‐Molero, B., Godoy‐Ruiz, R., & Medina‐Carmona, E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27072976 · Cited by 5 · see citing works

AZGP1: A proteomic biomarker in cancer

Pandey, S. N., Afzal, M., Ali, H., Malathi, H., Maharana, L., Goyal, K., Rana, M., & Imran, M. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120481 · Cited by 3 · see citing works

Multiplexed quantitative proteomics in prostate cancer biomarker development

Gao, Y., Kim, H., Kitata, R. B., Lin, T., Swensen, A., Shi, T., & Liu, T. (2024) · Advances in cancer research · doi:10.1016/bs.acr.2024.04.003 · Cited by 3 · see citing works

Exploring the extracellular transcriptome in seminal plasma for non-invasive prostate cancer diagnosisPreprint

Hulstaert, E., Morlion, A., Nuytens, J., Ponti, G., Maccaferri, M., Lau, S. A., Diamandis, E. P., Jarvi, K. A., Prassas, I., Lumen, N., et al. (2021) · medRxiv · doi:10.1101/2021.05.11.21256306 · Cited by 3 · see citing works

The proteomic toolbox for identification, quantification, and characterization of polyclonal antibodiesPreprint

Tang, W., & Drabovich, A. P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.27.564451 · Cited by 2 · see citing works

Bridging Andrology and Oncology: Prognostic Indicators of Cancer Among Infertile Men

Zachariou, A., Moustakli, E., Zikopoulos, A., Filiponi, Μ., Potiris, A., Kathopoulis, N., Grigoriadis, T., Tzeli, M., Machairiotis, N., Domali, E., et al. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47110930 · Cited by 1 · see citing works

Seminal Extracellular Vesicles LGALS3BP as a Potential Biomarker of Varicocele‐Associated Infertility in TMT‐Based Quantitative Proteomic Analysis

Yang, C., Li, J.-X., Lv, X.-Y., Zhou, R., Zhou, J.-H., Liu, C., & Zhao, S. (2026) · Andrologia · doi:10.1155/and/9374173 · Cited by 1 · see citing works

AI in multi-omics analysis in cancer

Ghosh, K., Saha, S., & Saha, S. (2026) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2026.03.010 · Cited by 1 · see citing works

Germ cell-specific proteins ACRV1 and AKAP4 facilitate identification of rare spermatozoa in semen of non-obstructive azoospermia patientsPreprint

Zhang, J., Kanoatov, M., Jarvi, K. A., Gauthier-Fisher, A., Moskovtsev, S. I., Librach, C. L., & Drabovich, A. P. (2022) · medRxiv · doi:10.1101/2022.09.15.22280011 · Cited by 1 · see citing works

Identification and Quantification of Autoantibodies against Prostate-Specific Antigens by Immunoaffinity-Mass SpectrometryPreprint

Rais, Y., & Drabovich, A. P. (2025) · medRxiv · doi:10.1101/2025.06.26.25330371 · Cited by 1 · see citing works

Multi-omic Approaches to Improve Cancer Diagnosis, Prognosis, and Therapeutics

Singla, D., & Sangha, M. K. (2022) · Studies in computational intelligence · doi:10.1007/978-981-16-9221-5_23

Recent Advances of Ultrasound-Based Nano-Delivery Systems in Prostate Cancer Imaging and TreatmentPreprint

Yang, L., Xie, X., zhang, J., & Du, Z. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4804071

Recent advances of ultrasound-based nano-delivery systems in prostate cancer imaging and treatment

Zhang, J., Wu, H., Xie, X., Yang, L., & Lu, D. (2025) · Results in Chemistry · doi:10.1016/j.rechem.2025.102690

Additional file 2 of Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables

Gabriele, C., Aracri, F., Prestagiacomo, L. E., Rota, M. A., Alba, S., Tradigo, G., Guzzi, P. H., Cuda, G., Damiano, R., Veltri, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26643058

Additional file 5 of Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables

Gabriele, C., Aracri, F., Prestagiacomo, L. E., Rota, M. A., Alba, S., Tradigo, G., Guzzi, P. H., Cuda, G., Damiano, R., Veltri, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26643067

Additional file 4 of Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables

Gabriele, C., Aracri, F., Prestagiacomo, L. E., Rota, M. A., Alba, S., Tradigo, G., Guzzi, P. H., Cuda, G., Damiano, R., Veltri, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26643064

Additional file 1 of Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables

Gabriele, C., Aracri, F., Prestagiacomo, L. E., Rota, M. A., Alba, S., Tradigo, G., Guzzi, P. H., Cuda, G., Damiano, R., Veltri, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26643055

Additional file 6 of Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables

Gabriele, C., Aracri, F., Prestagiacomo, L. E., Rota, M. A., Alba, S., Tradigo, G., Guzzi, P. H., Cuda, G., Damiano, R., Veltri, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26643070

Additional file 3 of Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables

Gabriele, C., Aracri, F., Prestagiacomo, L. E., Rota, M. A., Alba, S., Tradigo, G., Guzzi, P. H., Cuda, G., Damiano, R., Veltri, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26643061

Seminal Fluid Biomarkers for Early Cancer Detection: A Systematic Review

Sagitova, G. R., Slizova, A. V., Morozov, A., Fatyanova, A. S., Warkiani, M. E., Zvyagin, A. V., & Rzhevskiy, A. S. (2026) · Biomedicines · doi:10.3390/biomedicines14050966

The Q226H Mutation in Avian H5N1 Hemagglutinin Mediates a Path towards Structural Adaptation in HumansPreprint

Edwards, R. A., Adu, O. F., Tchesnokov, E. P., Kocíncová, D., Woolner, E., Turner, Z., Bui, D. T., Mahal, L. K., Zelyas, N. J., Klassen, J. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.21.726965 · Cited by 1 · see citing works

Seminal Plasma as a Source of Prostate Cancer Peptide Biomarker Candidates for Detection of Indolent and Advanced Disease

Neuhaus, J., Schiffer, E., von Wilcke, P., Bauer, H. W., Leung, H. Y., Siwy, J., Ulrici, W., Paasch, U., Horn, L., & Stolzenburg, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067514 · Cited by 48 · see citing works

Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry

Kagedan, D. J., Lecker, I., Batruch, I., Smith, C. R., Kaploun, I., Lo, K. C., Grober, E. D., Diamandis, E. P., & Jarvi, K. A. (2012) · Clinical Proteomics · doi:10.1186/1559-0275-9-2 · Cited by 38 · see citing works

Seminal plasma as a diagnostic fluid for male reproductive system disorders

Drabovich, A. P., Saraon, P., Jarvi, K. A., & Diamandis, E. P. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.74 · Cited by 211 · see citing works

Proteombasierte diagnostische und prognostische Biomarker beim Prostatakarzinom

Neuhaus, J., Schiffer, E., Siwy, J., Mannello, F., Horn, L., & Stolzenburg, J. ‐. (2013) · Der Urologe · doi:10.1007/s00120-013-3308-0 · Cited by 1 · see citing works

Exploring the extracellular transcriptome in seminal plasma for non-invasive prostate cancer diagnosisPreprint

Hulstaert, E., Morlion, A., Nuytens, J., Ponti, G., Maccaferri, M., Lau, S. A., Diamandis, E. P., Jarvi, K. A., Prassas, I., Lumen, N., et al. (2021) · medRxiv · doi:10.1101/2021.05.11.21256306 · Cited by 3 · see citing works